AnaptysBio (LTS:0HFQ) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0HFQ AnaptysBio Inc LTS:0HFQ
47 GF Score
Price $54.80
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is AnaptysBio FFO per Share?

FFO per Share only applies to REITs.

LTS:0HFQ
47GF Score
AnaptysBio Inc LTS:0HFQ
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AnaptysBio Business Description

Other Exchanges ANAB:USAAN6:Germany
Address 10770 Wateridge Circle, Suite 210, San Diego, CA, USA, 92121
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
47GF Score

Get the complete analysis for LTS:0HFQ

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$54.80
Price